Crenolanib Uses, Dosage, Side Effects and more
Crenolanib is under investigation for the treatment of Diffuse Intrinsic Pontine Glioma and Progressive or Refractory High-Grade Glioma.
| Trade Name | Crenolanib |
| Generic | Crenolanib |
| Crenolanib Other Names | Crenolanib |
| Type | |
| Formula | C26H29N5O2 |
| Weight | Average: 443.551 Monoisotopic: 443.232125194 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
